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Claudication distances and the Walking
Impairment Questionnaire best describe
the ambulatory limitations in patients with
symptomatic peripheral arterial disease
Sara A. Myers, MS,a Jason M. Johanning, MD,b,c Nick Stergiou, PhD,a,d Thomas G. Lynch, MD,b,c
G. Matthew Longo, MD,b,c and Iraklis I. Pipinos, MD, PhD,b,c Omaha, Neb
Background:Claudication secondary to peripheral arterial disease leads to reduced mobility, limited physical functioning,
and poor health outcomes. Disease severity can be assessed with quantitative clinical methods and qualitative self-
perceived measures of quality of life. Limited data exist to document the degree to which quantitative and qualitative
measures correlate. The current study provides data on the relationship between quantitative and qualitative measures of
symptomatic peripheral arterial disease.
Method:This descriptive case series was set in an academic vascular surgery unit and biomechanics laboratory. The subjects
were symptomatic patients with peripheral arterial disease patients presenting with claudication. The quantitative
evaluation outcome measures included measurement of ankle-brachial index, initial claudication distance, absolute
claudication distance, and self-selected treadmill pace. Qualitative measurements included the Walking Impairment
Questionnaire (WIQ) and the Medical Outcomes Study Short Form-36 (SF-36) Health Survey. Spearman rank
correlations were performed to determine the relationship between each quantitative and qualitative measure and also
between the WIQ and SF-36.
Results: Included were 48 patients (age, 62  9.6 years; weight, 83.0  15.4 kg) with claudication (ABI, 0.50  0.20).
Of the four WIQ subscales, the ankle-brachial index correlated with distance (r 0.29) and speed (r 0.32); and initial
claudication distance and absolute claudication distance correlated with pain (r  0.40 and 0.43, respectively), distance
(r 0.35 and 0.41, respectively), and speed (r 0.39 and 0.39 respectively). Of the eight SF-36 subscales, no correlation
was found for the ankle-brachial index, initial claudication distance correlated with Bodily Pain (r  0.46) and Social
Functioning (r  0.30), and absolute claudication time correlated with Physical Function (r  0.31) and Energy (r 
0.30). The results of both questionnaires showed reduced functional status in claudicating patients.
Conclusions: Initial and absolute claudication distances andWIQ pain, speed, and distance subscales are the measures that
correlated the best with the ambulatory limitation of patients with symptomatic peripheral arterial disease. These results
suggest the WIQ is the most specific questionnaire for documenting the qualitative deficits of the patient with
claudication while providing strong relationships with the quantitative measures of arterial disease. Future studies of
claudication patients should include both quantitative and qualitative assessments to adequately assess disease severity
and functional status in peripheral arterial disease patients. ( J Vasc Surg 2008;47:550-5.)
Peripheral arterial disease (PAD) affects approximately
8 to 12 million people in the United States.1 In addition to
its association with increased cardiovascular morbidity and
mortality, PAD leads to reduced mobility, reduced physical
functioning, and poor health outcomes.1-3 Disease severity
and functional status of PAD patients can be assessed using
quantitative clinical measures, such as ankle-brachial index
(ABI) and claudication distances, and qualitative, self-
perceived measures of quality of life (QOL). Despite a
wealth of studies documenting either quantitative or qual-
itative measures in patients with PAD, few studies have
documented the degree to which quantitative and qualita-
tive measures correlate. Conflicting data exist, with several
studies demonstrating significant correlations4-8 whereas
others show minimal if any correlation.9,10
What is clear is an absence of standardization in studies
evaluating PAD patients, evidenced by a variety of reported
quantitative test protocols and similar variation of qualita-
tive questionnaires. This lack of standardization makes it
difficult for physicians to choose the most appropriate
measures to evaluate patients, determine indications for
treatment, and consistently document and report treat-
ment outcomes. The purpose of this study was to deter-
mine the relationship between the most commonly used
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quantitative variables and the currently recommended self-
reported qualitative measures of physical function in PAD
patients.We also examined the correlation between the two
qualitative measures most commonly used in PAD.
METHODS
Peripheral arterial disease subjects. The study com-
prised of 48 symptomatic PAD patients diagnosed with
moderate arterial occlusive disease who experienced clau-
dication in at least one leg. Patients were recruited from the
vascular surgery clinics of the Nebraska and Western Iowa
Veterans Affairs Medical Center and the University of
Nebraska Medical Center. All study patients were symp-
tomatic and had been seen for initial evaluation of their
PAD with no prior treatment.
Patients were specifically evaluated and screened by two
vascular surgeons. This included a detailed history, physical
examination, and a direct assessment/observation of the
patient’s walking impairment. A vascular surgeon observed
the patient walking and recorded all symptoms and signs
affecting ambulation, ensuring that ambulatory limitation
was secondary to vasculogenic claudication. Excluded were
those patients with ambulation-limiting cardiac, pulmo-
nary, neuromuscular, or musculoskeletal disease or those
who experienced any pain or discomfort (evenmild) during
walking for any reason other than claudication, such as
arthritis, low back pain, musculoskeletal problems, and
neuropathy.
The presence and extent of disease was documented
with standard lower extremity noninvasive evaluation that
included measurement of ABI, femoropopliteal and tibial
duplex ultrasound imaging, and evaluation of Doppler
waveforms at the femoral, popliteal, and pedal levels. In
selected patients this was supplemented by computed to-
mography (CT), magnetic resonance imaging (MRI), or
invasive angiography. The level of disease was established
by the vascular surgeon after review of all available studies.
The study was approved by the Institutional Review
Boards of the Nebraska/Western Iowa VAMedical Center
and the University of Nebraska Medical Center. Written
informed consent was obtained from all subjects before
data collection.
Quantitative measures
Ankle-brachial index. The ABI values obtained dur-
ing the patient’s evaluation were used for the correlations.
The highest ABI value from the most symptomatic leg was
reported as the ABI for each subject.
Claudication distance. To determine the initial and
absolute claudication distances, patients walked on a tread-
mill at 0.67 m/s (1.5 mph) and 10% grade.11 The first
indication of claudication pain was recorded as initial clau-
dication distance, and the total distance the patients could
walk on the treadmill before stopping because of pain was
the absolute claudication distance.12 During the test, the
technician asked the patient to confirm the presence or
absence of pain to ensure the correct initial claudication
distance was recorded.
Self-selected speed. Subjects were given ample time
to familiarize themselves with walking on the treadmill
before beginning the test.13 To determine self-selected
speed, subjects walked on the treadmill at 1.61 km/h (1.0
mph) and were asked to adjust the speed up or down until
it matched their typical pace. Before walking on the tread-
mill, the subjects were shown how to adjust the speed.
Subjects were encouraged to choose the speed in a timely
manner (10-20 seconds) to avoid the onset of claudica-
tion while determining the preferred pace. This has been
shown to be enough time to attain a steady state for knee
kinematics and most spatial-temporal variables on a tread-
mill.14 The determination of the self-selected treadmill
pace was conducted as a separate test before the onset of
any claudication.
Qualitative measures
Physical function and health-related QOL were as-
sessed using the Walking Impairment Questionnaire
(WIQ)15 and the Medical Outcomes Study Short Form 36
(SF-36) Health Survey.16-18
Walking Impairment Questionnaire. The WIQ is a
disease-specific questionnaire validated in patients with in-
termittent claudication.4 It consists of four subcategories:
pain, distance, walking speed, and stair climbing.
Short Form 36. Eight health domains are assessed
with the SF-36: Physical Function, limitation due to Phys-
ical Health, limitation due to Emotional Problems, Energy,
Mental Health, Bodily Pain, General Health, and Social
Function. The SF-36 has been extensively evaluated and
tested with a variety of populations and is able to distin-
guish between groups of varying health status.16,19
The WIQ and SF-36 both use a scale from 0 to 100,
with a score of 0 representing the low score and 100 being
the high score. Specific descriptions of each subscale can be
found in the Appendix (online only). In the beginning of
our study, the SF-36 forms given to both PAD patients and
controls were missing the questions for the Limitations-
Physical and Limitations-Emotional domains. This was
corrected after more than half of all subjects were recruited
in the study.
Control subjects. The study recruited 25 healthy con-
trols matched for age, height, and weight. Controls had an
ABI 0.9 and absence of subjective or objective ambula-
tory dysfunction. Similar to PAD patients, control subjects
were excluded for the same ambulation-limiting condi-
tions. Control patients did not undergo treadmill testing
for the determination of claudication distances or self-
selected speed, but they did have a lower extremity nonin-
vasive evaluation to document the absence of appreciable
occlusive disease. They also completed theWIQ and SF-36.
Statistical analysis. Scores for ABI, initial claudica-
tion distance, absolute claudication distance, self-selected
walking speed, and the subscores of the WIQ and SF-36
were ranked for each subject. Spearman rank correlations
were performed between ABI, initial claudication distance,
absolute claudication distance, self-selected walking pace,
and each subscore of the questionnaires. In addition, rank
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correlations were calculated between the WIQ and SF-36.
If questions were not answered on the WIQ or SF-36, the
patient was excluded from the specific subscale analysis. All
analyses were performed using SPSS 14 statistical software
(SPSS Inc, Chicago, Ill) and tested at P  .05.
RESULTS
Demographic characteristics and results of the quanti-
tative clinical tests are summarized in Table I, and the mean
scores for each subscale of the SF-36 and theWIQ are listed
in Table II. Findings from noninvasive lower extremity
testing supplemented by data from CT, MRI, or invasive
angiography revealed that 52.1% of the patients had multi-
level disease consisting of a combination of aortoiliac, fem-
oropopliteal, and tibial levels of occlusive disease (Table I).
The remaining patients had single level disease, of which
19.6% had aortoiliac occlusive disease, 28.3% had femoro-
popliteal disease, and no patients had solely tibial occlusive
disease. No significant relationship was found between
occlusive disease levels and SF-36 and WIQ measures
(P  .05).
Three of the four quantitative measures had significant
correlations with one or more of the questionnaire sub-
scales (Tables II and III). The ABI had significant correla-
tions with the distance and speed components of the WIQ
but did not correlate with any of the SF-36 domains or with
any of the claudication distances. Initial claudication dis-
tance and absolute claudication distance had significant
correlations with several WIQ and SF-36 subscales. More
specifically, initial claudication distance and absolute clau-
dication distance both had significant correlations with the
pain, distance, and speed subscales of theWIQ. In addition,
absolute claudication distance correlated with Physical
Function and Energy, and initial claudication distance cor-
related with Bodily Pain and Social Functioning domains of
the SF-36.
Table 1. Averaged demographics and functional clinical measurements for peripheral arterial disease patients
Demographic characteristic a Control PAD P
Age, years 61.5  12.0 62.1  9.61 .834
Height, cm 174.2  7.7 169.8  16.2 .200
Weight, kg 84.0  22.1 83.0  15.4 .831
Ankle-brachial index 1.1  .1 0.50  0.20 .001
Aortoiliac disease, % NA 19.6 NA
Fem-pop disease, % NA 28.3 NA
Tibial disease, % NA 0 NA
Aortoiliac, fem-pop, tibial disease combined, % NA 52.1 NA
Claudication distance, m
Absolute NA 181.72  122.31 NA
Initial NA 47.61  22.79 NA
Self-selected treadmill speed, km/h 2.28  .53 2.47  .58 .001
NA, Not applicable; PAD, peripheral arterial disease.
aContinuous data are reported as the mean  standard deviation.
Table II. Averaged scores for each component of the Medical Outcomes Survey Short Form 36 Health Survey and the
Walking Impairment Questionnaire for peripheral arterial disease patients and controlsa
Questionnaire scale PAD patients Patients, no. Controls Controls, no. Pb
SF-36
Physical Function 41.5  20.1 48 95.3  6.2 25 .001
Limitations-Physical 33.3  44.0 16c 95.8  14.4 12c .001
Limitations-Emotional 71.1  45.2 16c 97.2  9.6 12c .061
Bodily Pain 46.1  27.6 48 75.0  12.5 25 .001
Energy 51.1  20.0 48 85.0  12.0 25 .022
Social Functioning 75.5  25.0 48 93.3  10.0 25 .001
Mental Health 75.3  18.8 48 94.1  12.5 25 .001
General Health 53.8  21.1 48 81.1  14.2 25 .001
WIQ
Pain 52.6  23.6 48 99.5  2.5 25 .001
Distance 55.0  42.3 48 99.8  0.6 25 .001
Speed 48.3  30.4 48 96.8  6.6 25 .001
Stairs 56.5  47.1 48 98.1  4.6 25 .001
PAD, peripheral arterial disease; SF-36, Medical Outcomes Survey Short Form 36 Health Survey; WIQ , Walking Impairment Questionnaire.
aSignificance levels are reported for t tests between patients with peripheral arterial disease and controls; significance level was P  .05. Continuous data are
reported as mean  SD.
bSignificance level was P  .05.
cThe questions for these subscales were missing from the SF-36 forms at the beginning of the study. This was corrected after more than half of all subjects were
recruited in the study.
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Of all correlations, those between claudication dis-
tances (initial and absolute) and the WIQ pain, distance,
and speed components were the strongest. Weaker were
the correlations between claudication distances and SF-36
domains, and the weakest correlation was noted between
the ABI and the WIQ subscales. Self-selected pace had
no significant correlations with any of the questionnaires’
subscales.
The correlation coefficients between the questionnaire
subscales indicated that many subscales from the question-
naires had significant correlations (Table IV). The WIQ
pain, distance, speed, and stair components were each
correlated with six or more domains of the SF-36. Both the
WIQ and the SF-36 results indicated reduced functional
status in PAD patients compared with healthy controls
(Table II). Compared with controls, PAD patients exhib-
ited significantly (P .5) lower scores for all four subscales
of the WIQ and for seven of the SF-36 domains, with the
eighth domain approaching significance (P  .061).
DISCUSSION
Our study demonstrates that initial and absolute clau-
dication distances are the quantitative tests with the highest
and most consistent correlation with qualitative measures.
Furthermore, the WIQ is the qualitative measure that best
reflects actual ambulatory performance of the PAD pa-
tients. More specifically, pain, distance, and speed (with the
pain subscale being the strongest) appear to be the WIQ
subscales that more thoroughly describe the ambulation-
related limitations of PAD patients. When we compared
quantitative clinical measures with questionnaire subscale
scores, we found 12 of 48 comparisons (25.0%) were
significantly related. Of the quantitative measures, the ab-
solute claudication distance and initial claudication distance
Table III. Correlation matrix between quantitative clinical measures and the qualitative self-perceived measures of
functional status
Qualitative measure Patients, no.
Quantitative measure
ABI Absolute claudication distance Initial claudication distance SS pace
SF-36
Physical Function 48 0.26 0.31a 0.23 0.01
Limitations-Physical 16b 0.01 0.38 0.15 0.15
Limitations-Emotional 16b 0.10 0.26 0.24 0.05
Bodily Pain 48 0.13 0.26 0.46a 0.07
Vitality 48 0.10 0.30a 0.26 0.06
Social Functioning 48 0.07 0.28 0.30a 0.10
General Mental Health 48 0.05 0.21 0.24 0.02
General Health 48 0.08 0.09 0.01 0.13
WIQ
Pain 48 0.01 0.43a 0.40a 0.07
Distance 48 0.29a 0.41a 0.35a 0.01
Speed 48 0.32a 0.39a 0.39a 0.08
Stairs 48 0.11 0.21 0.19 0.05
SF-36, Medical Outcomes Survey Short Form 36 Health Survey; SS, self-selected pace; WIQ , Walking Impairment Questionnaire.
aSignificant correlations (P  .05).
bThe questions for these subscales were missing from the SF-36 forms at the beginning of the study. This was corrected after more than half of the subjects were
enrolled.
Table IV. Correlation matrix between the Medical Outcomes Survey Short Form 36 Health Survey and the Walking
Impairment Questionnaire subscales
SF-36 Patients, no.
Walking impairment questionnaire
Pain Distance Speed Stairs
Physical Function 48 0.36a 0.47a 0.42a 0.51a
Limitations-Physical 16b 0.19 0.36 0.33 0.41
Limitations-Emotional 16b 0.57a 0.28 0.31 0.64a
Bodily Pain 48 0.34a 0.44a 0.53a 0.48a
Energy 48 0.54a 0.65a 0.52a 0.60a
Social Functioning 48 0.43a 0.45a 0.40a 0.38a
General Mental Health 48 0.36a 0.42a 0.40a 0.27a
General Health 48 0.42a 0.30a 0.24 0.32a
SF-36, Medical Outcome Study Short Form 36 Health Survey.
aSignificant correlations (P  .05).
bThe questions for these subscales were missing from the SF-36 forms at the beginning of the study. This was corrected after more than half of all subjects were
recruited in the study.
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were related with the largest number of subscales of the
questionnaires. The pain, distance, and speed components
of the WIQ all correlated with both the absolute and initial
claudication distances. Our finding is in agreement with
previous work on WIQ validation5 and suggests that either
test (absolute and initial claudication distances) could be
used as a quantitative measure of physical function.
The ABI correlated significantly with two WIQ sub-
scales, again indicating the WIQ may be the most specific
questionnaire to capture both the physiologic (reflected by
ABI) and quantitative ambulatory dysfunction (reflected by
claudication distances) associated with PAD and claudica-
tion. Different domains of SF-36 demonstrated correlation
with the quantitative measures, but unlike WIQ subscales,
no single SF-36 subscale consistently related with them,
again suggesting that the SF-36 (as a general QOL mea-
sure) is less suitable than WIQ in fully describing the
ambulatory limitation of claudicant patients.
In contrast with claudication distances, self-selected
speed did not correlate with any qualitative measures. Our
data demonstrated that self-selected pace exhibited no sig-
nificant correlation with the WIQ or SF-36 scores. There-
fore, our results suggested that self-selected walking pace
itself is not a predictor of QOL in patients with symptom-
atic claudication.
Previous studies have compared different quantitative
measures with self-reportedQOLmeasures, and our results
strengthen and add to their findings. Izquierdo-Porrera
et al6 calculated Pearson correlations between the ABI,
time to maximal claudication, and distance walked in 6
minutes with all domains of the SF-36 and with the dis-
tance, stair, and speed components of the WIQ (the WIQ
pain subscale was not included in their study). Of the 36
associations evaluated, 18 were found to be significant.
A study by Regensteiner et al5 related maximal walking
time and time to onset of claudication with individual
questions from the WIQ in 26 PAD patients. A total of
22 comparisons were made and 10 were significant.
McDermott et al20 performed linear regression analysis
between ABI category (0.9 to 1.5, 0.4 to 0.9, and
0.4) and subscales of the WIQ and SF-36 in 158 PAD
patients with a variety of leg symptoms. Results of the
regression analyses between ABI and WIQ found that ABI
was a predictor of walking distance and speed when the
PAD group was evaluated in its entirety. However, when
the effect of leg symptoms, comorbidities, and previous
revascularization were removed, ABI only predicted walk-
ing distance. For the analyses with SF-36 domains, ABI was
not independently associated when controlling for leg
symptoms and comorbid diseases.
These results are consistent with our findings showing
that the WIQ more appropriately describes problems
caused by flow limitations than the SF-36, which is a more
general measure of QOL. McDermott et al20 also pointed
out that ABI is less predictive of leg function in patients
with claudication (similar to our study population) com-
pared with PAD patients with varying leg symptoms, in-
cluding asymptomatic, claudication, and rest pain. This is
consonant with our finding that claudication distances are
more related with QOL than ABI values.
Our study is also in agreement with prior work demon-
strating PAD patients have reduced QOL1,6 and that this
QOL deterioration is similarly reflected in both WIQ and
SF-36 scores. When relating the SF-36 and the WIQ, 26 of
the 32 comparisons (81.3%) were significantly related. Our
results are in accordance with those of Izquierdo-Porrera
et al,6 which demonstrated significant correlations between
22 of the 24 comparisons between WIQ and SF-36.
Although the SF-36 is a generic measure of health-
related QOL and theWIQ is a disease-specific measure, the
significant correlations in 80% of the comparisons be-
tween them shows that both questionnaires can be useful in
providing information about the QOL of PAD patients. In
the absence of SF-36 data, WIQ can adequately reflect an
overall drop in QOL in claudicant patients.
Our study is unique because careful screening was used
to exclude patients with any gait dysfunction—even mild
ones—other than claudication. Because of this strict exclu-
sion criterion, our data accurately reflect that the ambula-
tory andQOL limitation are due solely to claudication. Our
results, however, may not be reflective of the overall PAD
population because claudicant patients frequently have co-
morbidities, such as osteoarthritis, neurogenic claudica-
tion, and peripheral neuropathy, that affect walking in
varying degrees.21-23
CONCLUSION
Our data demonstrated that absolute and initial claudi-
cation distances, and WIQ pain, speed, and distance sub-
scales are the measures with the best ability to describe the
ambulatory limitation of claudicant patients and also closely
relate to their QOL. It is our opinion that future claudica-
tion research should include, at a minimum, both quanti-
tative and qualitative measures consisting of claudication
distances and WIQ scores. These complementary measures
are essential and requisite tools to adequately characterize
and determine the degree of a PAD patient’s impairment.
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APPENDIX (online only). Description of the scales from the Medical Outcomes Study Short Form 36 (SF-36) Health
Survey and the Walking Impairment Questionnaire (WIQ). For the SF-36, a low score of represents significant
limitations and problems in the particular scale, and a score of 100 means no problems or limitations for that scale. The
WIQ scales each range from 0 to 100, with 0 meaning inability to complete the specific task and 100 representing no
difficulty in completing the task
Questionnaire subscale Description of scale concepts
SF-36
Physical functioning Represents levels and types of limitations in performing physical activities
Limitations due to physical problems Defines role limitations because of physical health problems
Limitations due to emotional problems Defines role limitations because of personal and emotional health problems
Bodily pain Represents frequency of pain and the extent that pain interferes with normal activities
Vitality Summarizes energy level and fatigue
Social functioning Assesses the impact of physical health problems on social activities
General mental health Summarizes mental health by assessing anxiety, depression, loss of control and
psychological well-being
General health Overall assessment of health perceptions
WIQ
Pain Describes amount of difficulty with walking due to pain in lower extremities
Distance Expresses amount of difficulty to walk specific distances, ranging from less than 50
feet to 1500 feet
Speed Describes amount of difficulty to cover 1 block at different speeds, from walking
slowly to a run or jog
Stairs Assesses difficulty to climb 1, 2, and 3 flights of stairs
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